FDA Approved: ARFORMOTEROL TARTRATE — Original Application (Cipla USA Inc.)

View source ↗

Summary

FDA approves Cipla USA's original application for arformoterol tartrate, a generic long-acting beta-agonist for maintenance treatment of chronic obstructive pul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• ARFORMOTEROL TARTRATE (arformoterol tartrate)

Snippet

ORIG AP for ARFORMOTEROL TARTRATE (ARFORMOTEROL TARTRATE)